Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Needle-free jet injection of triamcinolone + fluorouracil for hypertrophic scars
2019-001066-15Phase 2Completed
- Sponsor
- Merete Hædersdal
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of triamcinolone acetonide and fluorouracil in Hypertrophic Scar (HS), sponsored by Merete Hædersdal. Primary endpoints: Mean change in hypertrophic scar height and Standardized clinical photography. Started Apr 2019; status: completed.
02
Drugs
triamcinolone acetonidefluorouracil
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on 2019-001066-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001066-15.